Unilever won't top $68B bid for GSK consumer healthcare unit
Unilever says it won't increase a $68.2 billion offer for GlaxoSmithKline's consumer healthcare unit that was rejected last week.
Unilever says it won't increase a $68.2 billion offer for GlaxoSmithKline's consumer healthcare unit that was rejected last week.